AIXIAL GROUP
Sara Villeneuve is a seasoned pharmaco-epidemiologist currently working at AIXIAL since July 2021, with previous roles as an epidemiologist and biostatistician at CPias Ile-de-France and IQVIA. Sara's extensive experience includes significant contributions to epidemiological studies on occupational exposure and health outcomes, particularly in cancer, rheumatoid arthritis, and chronic conditions. Educational qualifications include a PhD in Epidemiology from the Faculté de médecine du Kremlin Bicêtre, supplemented by multiple advanced degrees in biostatistics, bioinformatics, and mathematics. Throughout a career spanning over a decade, Sara has engaged in various research projects, including the development of exposure matrices and patient registries, showcasing a strong foundation in statistical analysis and epidemiological methods.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
AIXIAL GROUP
2 followers
Bringing reliability and expertise to clinical development. Aixial Group is a specialized clinical development partner with the commitment, expertise, and flexibility needed to deliver efficient clinical trials. Aixial Group provides the industry with an innovative and scalable offering, which includes: comprehensive clinical trial design and execution; functional service delivery; resources and platform. For more information, please visit: aixialgroup.com Service Delivery Models: • End to End Clinical Trial Services • Functional Service Provider (FSP) Model • Business Process Outsourcing (BPO) Model • Expert Consulting & Advice • Resourcing & Staffing